NCT06843551
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06843551
Title The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation (EMPIRE)
Acronym EMPIRE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Benjamin Spieler
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.